Search

Author/Creator Grady, A.O

1. ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib. (December 2019)

Authors:
Thunnissen, E.; Lissenberg-Witte, B.I.; van den Heuvel, M.M.; Monkhorst, K.; Skov, B.G.; Sørensen, J.B.; Mellemgaard, A.; Dingemans, A.M.C.; Speel, E.J.M.; de Langen, A.J.; Hashemi, S.M.S.; Bahce, I.; van der Drift, M.A.; Looijen-Salamon, M.G.; Gosney, J.; Postmus, P.E.; Samii, S.M.S.; Duplaquet,...
Journal:
Lung cancer
Issue:
Volume 138(2019)
Page Start:
13
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search